The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine
- 1 February 1993
- journal article
- Published by Elsevier in Brain Research
- Vol. 603 (2) , 186-200
- https://doi.org/10.1016/0006-8993(93)91237-m
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Comparison of the antinociceptive and motor effects of intrathecal opioid agonists in the ratBrain Research, 1991
- Cardiovascular responses to κ opioid agonists in intact and adrenal demedullated ratsEuropean Journal of Pharmacology, 1988
- Evaluation of opioid‐induced antinociceptive effects in anaesthetized and conscious animalsBritish Journal of Pharmacology, 1988
- κ‐Opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the ratBritish Journal of Pharmacology, 1988
- Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonistEuropean Journal of Pharmacology, 1988
- Cardiovascular effects of dynorphin A (1–13) in conscious rats and its modulation of morphine bradycardia over timePeptides, 1987
- Naloxonazine actions in vivoEuropean Journal of Pharmacology, 1986
- Naloxonazine, a potent, long-lasting inhibitor of opiate binding sitesLife Sciences, 1982
- Analogues of β-LPH61–64 posessing selective agonist activity at μ-opiate receptorsEuropean Journal of Pharmacology, 1981
- Cardiovascular effects of intravenous morphine in the anaesthetized ratEuropean Journal of Pharmacology, 1971